【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Disease Overview
05.1 Understanding the Disease
05.2 Classification
05.2.1 Small Cell Carcinoma
05.2.2 Combined Small Cell Carcinoma
05.3 Diagnosis
05.3.1 Physical Examination
05.3.2 Laboratory Tests
05.3.3 Chest X-ray
05.3.4 Sputum Cytology
05.3.5 CT Scan
05.3.6 Biopsy
05.3.7 Light and Electron Microscopy
05.3.8 Immunohistochemistry
05.4 Rate of Incidence and Prevalence
05.5 Staging
05.6 Management
05.7 Economic Burden
06.Introduction
07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Top Predictions
07.4 Five Forces Analysis
08 Pipeline Analysis
08.1 Key Information on the Pipeline Candidates
08.1.1 Palifosfamide (ZIO-201)
08.1.2 Ipilimumab+Etoposide+Cisplatin/Carboplatin
08.1.3 Ipilimumab
08.1.4 Enoxaparin Sodium
08.1.5 BAY1000394 (Roniciclib)
08.1.6 Nivolumab (ONO-4538/ BMS-936558)
08.1.7 BMS-986012
08.1.8 LY2940680
08.1.9 Sabarubicin (MEN 10755)
08.1.10 CAP7.1
08.1.11 SC16LD6.5
08.1.12 BIW-8962
08.1.13 AMG 479 (Ganitumab)
08.1.14 LY2510924
08.1.15 Trisenox
08.1.16 MGN1703
08.1.17 Tarextumab (OMP-59R5)
08.1.18 BMN 673 (Talazoparib Tosylate)
08.1.19 NGR-hTNF
08.1.20 CPI-613
08.1.21 Alisertib (MLN8237)
08.1.22 Vismodegib (GDC-0449, Erivedge)
08.1.23 Cabozantinib (XL184 or Cometriq)
08.1.24 Selinexor (KPT-330)
08.1.25 ADI-PEG 20 (Pegargiminase)
08.1.26 Etirinotecan Pegol (NKTR-102)
08.1.27 CRLX101 (IT-101 or Cyclodextrin-based Polymer-camptothecin IT-101)
08.1.28 NTX-010
08.1.29 Aldoxorubicin
08.1.30 HA-Irinotecan
08.1.31 Carfilzomib
08.1.32 Small Cell Lung Cancer Vaccine
08.1.33 GSK2879552
08.1.34 NV-344 (ME-344)
08.1.35 BMS-833923 (XL139)
08.1.36 PM01183 (Lurbinectedin)
08.1.37 LDE225 (Erismodegib or Sonidegib)
08.1.38 Belinostat
08.2 Timeline for Major Products under Development
08.2.1 Palifosfamide (ZIO-201)
08.2.2 Sabarubicin (MEN 10755)
09.Market Segmentation by Therapeutic Class of Drugs
09.1 Alkylating Agents
09.2 Antimetabolites
09.3 Microtubule Inhibitors
09.4 Cytotoxic Antibiotics
09.5 Topoisomerase Inhibitors
09.6 Others
10 Market Segmentation by Route of Administration
10.1 Oral
10.2 Parenteral
11 Market Segmentation by Dosage Form
11.1 Solid
11.2 Liquid
12 Geographical Segmentation
12.1 Small Cell Lung Cancer Market in Americas
12.1.1 Market Size and Forecast
12.2 Small Cell Lung Cancer Market in EMEA Region
12.2.1 Market Size and Forecast
12.3 Small Cell Lung Cancer Market in APAC Region
12.3.1 Market Size and Forecast
13 Buying Criteria
14 Market Growth Drivers
15 Drivers and their Impact
16 Market Challenges
17 Impact of Drivers and Challenges
18 Market Trends
19 Trends and their Impact
20 Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Bristol-Myers Squibb
20.2.2 GlaxoSmithKline
20.2.3 Menarini
20.2.4 Sanofi
20.2.5 ZIOPHARM Oncology
20.3 Other Prominent Vendors
21 Key Vendor Analysis
21.1 Bristol-Myers Squibb
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Key Product Offerings
21.1.4 Revenue by Geography
21.1.5 Business Strategy
21.1.6 Key Information
21.1.7 SWOT Analysis
21.2 GlaxoSmithKline
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Pipeline Products
21.2.7 Business Strategy
21.2.8 Key Information
21.2.9 SWOT Analysis
21.3 Menarini
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Key Pipeline Products
21.3.4 Recent Developments
21.3.5 SWOT Analysis
21.4 Sanofi
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 ZIOPHARM Oncology
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Recent Developments
21.5.4 SWOT Analysis
22 Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Classification of Lung Cancer
Exhibit 3: Techniques for Diagnosing Small Cell Lung Cancer
Exhibit 4: Incidence of Lung Cancer in WHO Regions
Exhibit 5: Staging of Small Cell Lung Cancer
Exhibit 6: Small Cell Lung Cancer by Stage
Exhibit 7: Five-year Survival Rate of Small Cell Lung Cancer Patients
Exhibit 8: Stepwise Diagrammatic Representation of Management of Small Cell Lung Cancer (According to ESMO Guidelines)
Exhibit 9: Global Small Cell Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 10: Top Predictions in Global Small Cell Lung Cancer Therapeutics Market
Exhibit 11: Pipeline Portfolio of Small Cell Lung Cancer Drugs
Exhibit 12: Timeline of Palifosfamide (ZIO-201)
Exhibit 13: Timeline of Sabarubicin (MEN 10755)
Exhibit 14: Global Small Cell Lung Cancer Therapeutics Market by Therapeutic Class of Drugs
Exhibit 15: Segmentation of Global Small Cell Lung Cancer Therapeutics Market by Route of Administration
Exhibit 16: Segmentation of Global Small Cell Lung Cancer Therapeutics Market by Route of Administration 2014
Exhibit 17: Segmentation of Global Small Cell Lung Cancer Therapeutics Market by Dosage Forms
Exhibit 18: Segmentation of Global Small Cell Lung Cancer Therapeutics Market by Dosage Forms 2014
Exhibit 19: Segmentation of Global Small Cell Lung Cancer Therapeutics Market by Geography 2014
Exhibit 20: Segmentation of Global Small Cell Lung Cancer Therapeutics Market by Geography 2019
Exhibit 21: Small Cell Lung Cancer Therapeutics Market in Americas 2014-2019 (US$ million)
Exhibit 22: Small Cell Lung Cancer Therapeutics Market in EMEA Region 2014-2019 (US$ million)
Exhibit 23: Small Cell Lung Cancer Therapeutics Market in APAC Region 2014-2019 (US$ million)
Exhibit 24: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 25: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 26: GlaxoSmithKline: Business Segmentation 2013
Exhibit 27: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 28: GlaxoSmithKline: Sales by Geography 2013
Exhibit 29: GlaxoSmithKline: Pipeline Products 2013
Exhibit 30: Menarini: Key Pipeline Products
Exhibit 31: Sanofi SA: Business Segmentation
Exhibit 32: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 33: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 34: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：小細胞肺がん治療薬の世界市場2015-2019■ 英文：Global Small Cell Lung Cancer Therapeutics Market 2015-2019
■ 発行日：2015年3月18日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5579
■ 調査対象地域：グローバル
- 自動車用イベントデータレコーダー（EDR）の世界市場2017-2021About Automotive Event Data Recorder An EDR is a device installed in a vehicle for recording the operation of vehicle systems for a few seconds (close to 20 seconds) during the time of occurrence of an accident. The recordings are predominantly used for assessing the functioning and effectiveness of vehicle systems during and after accidents. It is imperative to note that neither can the data in E …
- 世界のスマートフォン電源管理IC市場：価格別、地域別Global Smartphone Power Management IC Market: About this market Technavio’s smartphone power management IC market analysis considers sales from premium range, medium-range, and low range prices. Our study also finds the sales of smartphone power management IC in APAC, the Americas, and EMEA. In 2019, the premium range segment had a significant market share, and this trend is expected to continue o …
- イムノアッセイ（免疫測定法）の世界市場2015-2022According to Stratistics MRC, the global immunoassay market is estimated at $16.35 billion in 2015 and is expected to grow at a CAGR of 10.9% to reach $33.72 billion by 2022. Technological advancements and increasing geriatric population worldwide are some of the key factors fuelling the market growth. Increasing incidences of infectious & chronic diseases, demand for non-invasive diagnostic techn …
- 金属代替材料の世界市場予測：エンジニアリング・プラスチック、複合材料The metal replacement market is projected to reach USD 159.82 Billion by 2021, at a CAGR of 9.2% from 2016 to 2021. The key factor propelling the growth of the metal replacement market is the increasing demand for metal replacing materials from the automotive and aerospace & defense industries. Major end-use industries in the metal replacement market include automotive, aerospace & defense, constr …
- デジタルサイネージの世界市場Digital signage is an advertising medium which helps to strike the perfect balance between the advertisement and the targeted audience. Traditional advertising media such as print medias concerned with several issues such as high costs, low web connectivity, low rate to attract consumer, inability to update content, difficulty in influencing purchase decisions. To overcome these issues, various di …
- 2014年戦略提言：アメリカの病院腫瘍マーカー検査市場This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics a …
- ソーヤ・レシチンの世界市場Soya Lecithin (CAS 8002-43-5) Market Research Report 2013 presents comprehensive data on Soya lecithin markets globally and regionally (Europe, Asia, North America etc.) The Soya Lecithin (CAS 8002-43-5) Market Research Report 2013 includes Soya lecithin description, covers its application areas and related patterns. It overviews Soya lecithin market, names Soya lecithin producers and indicates it …
- 淋疾(Gonorrhea)：世界の治験レビュー（2015年上半期版）Gonorrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Gonorrhea Global Clinical Trials Review, H1, 2015" provides data on the Gonorrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gonorrhea. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- プロテオミクスの世界市場予測（～2024年）“The proteomics market is projected to grow at a CAGR of 14.1% during the forecast period (2019–2024).”The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%. An increase in the research activity, especially in the area of personalized medicine and drug discovery is the primary growth driver for this market. In addition, the increasin …
- 走査型プローブ顕微鏡（SPM）の世界市場：AFM（原子間力顕微鏡）、STM（走査型トンネル顕微鏡）About scanning probe microscopes Scanning probe microscope (SPM) is an advanced microscope that uses a physical probe to scan the specimen. These microscopes provide high magnification and are specifically used for observation of three-dimensional specimens. In 1981, it was introduced as a pioneer in providing high atomic resolution. Initially, SPMs were mainly used for measuring 3D surface topogr …
- 防錆塗料の世界市場：溶剤型防錆塗料、水性防錆塗料、粉体防錆塗料The global market size of anti-corrosion coating is projected to reach USD 30.04 Billion by 2021, registering a CAGR of 5.1% between 2016 and 2021. The growing marine end-use industry in all regions is expected to generate demand and drive the anti-corrosion coating market during the forecast period. The marine end-use industry accounted for the largest share of the anti-corrosion coating market i …
- ヤギ乳の世界市場：製品別（牛乳、チーズ、粉乳、その他）、流通経路別（ハイパーマーケットおよびスーパーマーケット、コンビニ、専門店、医療および薬局、オンライン）Goat milk comes with maximum nutritional properties as compared to cattle milk. It is categorized into various products such as milk, milk powder, cheese, yogurt, butter, and other products. It has many health benefits. It contains low level of cholesterol, and is easier to digest. According to the Food and Agriculture Organization (FAO), India, Bangladesh, and Pakistan are the major producers of …
- 2014年戦略提言：アメリカの血液凝固検査市場Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.SummaryThis comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. The report explores business and technologic …
- 欧州の加工でん粉市場分析・予測The European modified starch market is estimated to grow at a CAGR of 3.9% during the forecast period, 2015 to 2020. The purpose of this study is to analyze the European market for modified starch. The report describes various factors responsible for the growth of modified starch market in this region. The major sources of starch include corn, potatoes, wheat, and cassava. The starch derived from …
- 保護フィルムの世界市場予測（～2022年）The protective films market is projected to reach USD 17.57 billion by 2022, at a CAGR of 6.23% from 2017 to 2022. Increasing demand for protective films from the building and construction industry and the transportation industry especially from the automotive sector are the major drivers for the growth of the protective films market. The difficulty in recycling polymer based protective films act …
